Close

Intercept Pharmaceuticals (ICPT) PT Raised to $500 at Deutsche Bank

August 12, 2014 10:31 AM EDT Send to a Friend
Deutsche Bank maintained a Buy rating on Intercept Pharmaceuticals (NASDAQ: ICPT) and a raised its price target to $500.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login